Staff

	Amy Efantis President & CEO
Global Initiatives
John Delacourt Chief Legal Officer and Vice President, Global Initiatives	Larisa Cervenakova Medical Director	George Schreiber Director Epidemiology
Brenna Raines Assistant Director Global Health Policy	Abigail Glaser Coordinator Global Initiatives
Source & International Affairs
Joshua Penrod Senior Vice President Source & International Affairs	Sonia Balboni Director Source & Standards	Alexa Wetzel Director Source Europe
Julia Fabens Assistant Director International Affairs	Brenda Norman Senior Manager Data	Diana Krueger Manager IQPP Audits
	Bobbi Stackman Coordinator Source & International Affairs
Regulatory & Quality Policy
Mary Gustafson Vice President Global Regulatory Policy	Dominika Misztela Senior Director Regulatory Policy Europe	Bill Speir Senior Director Advocacy and Regulatory Policy
Michelle Fransen Project Manager Health Initiatives	Michelle Mason Coordinator Global Regulatory Policy/ QSEAL Administrator
Public Affairs, Europe
Maarten Van Baelen Executive Director Europe	Karl Petrovsky Director Health Policy	Sándor Tóth Director Government Affairs and Health Policy
Athina Giannoutsou Manager Public Affairs	Melanie Conrads Executive Assistant
Public Affairs, North America
Julie Birkofer Senior Vice President Public Affairs	Tom Lilburn Senior Director Government Relations	Mat Gulick Senior Director Global Communications
Tim Swope Assistant Director Government Relations	Rachel Liebe Manager Global Communications	Manisha Vasudeva Communications Specialist Global Communications
	April O'Neal Executive Assistant
Finance & Operations
Gene Stroshane Senior Director Finances & Operations	Cathy Izzi Senior Director Human Resources & Administrative Services	Mike McCormick Director IT & Facilities
	Charon Smith Senior Manager Accounts Receivables/Payables

PPTA News

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients +

February 25, 2021 (Annapolis, MD) - The Plasma Protein Therapeutics Association (PPTA) welcomes the decision of the UK government to lift a two decades old ban on the use of UK-donated plasma for the manufacture of immunoglobulins, following a scientific review conducted by the Medicines and Healthcare Products Regulatory Agency. The ban was imposed in 1998 to mitigate the spread of variant Creutzfeldt Jakob Disease (vCJD), but experts have now concluded that the use of UK-sourced plasma to manufacture immunoglobulins is safe and can recommence, supported by a set of robust safety measures.
Read More
Human Plasma Donations Remain Important During COVID-19 Pandemic +

In a recent communication, the U.S. Food and Drug Administration (FDA) limits the collection and use of COVID-19 convalescent plasma authorized under Emergency Use Authorization for the treatment of hospitalized patients with COVID-19.¹ It is important to note, however, that this development does not mean that the need for plasma donations has diminished. Both normal source plasma donations, from healthy individuals, and convalescent plasma donations, from individuals who have recovered from COVID-19, are still needed to fight COVID-19 and the many non-COVID-19 conditions (e.g., immune deficiencies and blood clotting disorders) for which plasma protein therapies are ordinarily used.
Read More
PPTA Statement on Immunoglobulin Use to Meet Clinical Need +

A recent publication¹ explores possible reasons for the increased use of immunoglobulins (IG) and suggests growing clinical need can be met by restricting patient access to IG while denying the need to collect more plasma in Europe. With a global mission rooted in promoting the availability of, and access to, plasma-derived therapies for all patients who need them, the Plasma Protein Therapeutics Association (PPTA) disagrees with these suggestions and remains dedicated to its long-standing commitment to supporting patients and to expanding plasma collection, particularly in Europe.
Read More
PPTA Statement on the Inauguration of President Biden +

The Plasma Protein Therapeutics Association (PPTA) and its member companies wish success to President Biden, Vice President Harris, and the dedicated public servants of their Administration as we join them to improve the health of all Americans.
Read More

1
2
3

› ‹

Mission Video

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap